Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03920345
Other study ID # MULTI-2018-05-31
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date June 8, 2018
Est. completion date May 16, 2019

Study information

Verified date July 2019
Source joimax, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

1. Determine the rate and incidence of peri-operative & post-operative adverse events (complications, infections, re-operations, re-admissions) in the endoscopic approach for the treatment of SIJ arthropathy and chronic lower back pain (CLBP).

2. Determine the Health-Related Quality of Life (HRQoL) using EQ-5D scale, VAS (Visual Analog Scale) & ODI (Oswestry Disability Index), outcomes following the endoscopic approach for the treatment of SIJ arthropathy and chronic lower back pain (CLBP) (pre- to post-operative changes).


Description:

Chronic low back pain (CLBP) that lasts for more than six months is estimated to occur in 60-80% of the general population in their lifetime and is associated with substantial healthcare costs. The sacroiliac joint (SIJ) complex is one of the major sources of CLBP, accounting for around 10-33% of the total number of CLBP cases. The SIJ complex consists of the joint capsule, synovia, various muscles and ligamentous structures overlying the join and neuronal structures that innervate the SIJ. Current interventional and surgical treatment options for SIJ complex mediated CLBP include intraarticular and periarticular injection of the joint, SIJ fusion and radio frequency ablation (RFA) of the neuronal structures innervating the SIJ. The described interventional procedures are simple procedures and provides quick pain relief, but the effect is short-lived. In addition, SIJ fusion is an invasive surgical procedure that should be reserved for refractory intractable pain of the SIJ1.

New endoscopic electrothermic ablation of the SIJ capsula, synovial and neuronal structures have been utilized in the treatment of facetogenic CLBP in a few number of clinical reports with favorable results, but to our knowledge, the efficacy of this technique when applied to SIJ-associated CLBP has not been reported. In this study, the investigators will utilize endoscopy for the precise microsurgical and ablation (ESIJ) of the potential pain generators associated with the SIJ and evaluate the clinical efficacy of this new technique.


Recruitment information / eligibility

Status Terminated
Enrollment 5
Est. completion date May 16, 2019
Est. primary completion date May 16, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

Subject age 18 - 85 years;

- SIJ arthropathy and chronic lower back pain (CLBP);

- Patient to undergo endoscopic electrothermic ablation of spinal levels S1-S3. The L4-L5 and/or L5-S1 facet joint can be included in the ablation per doctor discretion.

- Correct spinal levels (ranging L4-S3) to be treated have been confirmed by 1) diagnostic SIJ injection, followed by 2) diagnostic Medial/Lateral Branch Block at the applicable levels.

- The subject is likely to follow standard of care post-operative follow-up for at least 24 months.

Exclusion Criteria:

Patients receiving additional invasive back surgery after the study treatment.

- Inability to complete follow-up visits or required questionnaires.

- Non-compliant patients

- Difficult or impossible communication with the patient

- Breastfeeding, pregnant or patients who plan a pregnancy while participating in the study

- Systemic neurological disorders with mobility limitations (e.g. advanced Parkinson's disease or multiple sclerosis)

- Patients with incompatibilities or known limitations that make participation impossible

- Patients after stabilization with implants on thoracic or lumbar spine.

- Inability to provide informed consent without a legally authorized representative.

Study Design


Intervention

Device:
MultiZYTE
Subjects can be treated either unilateral or bilateral, depending on their condition and the recommended treatment by the surgeon. The decision is a clinical one and is not influenced by the decision of whether to be included in the study or the subsequent outcomes and QoL analysis.

Locations

Country Name City State
United States Dr. Daniel Hanson Maple Grove Minnesota
United States Dr. Azmi Nasser Mesa Arizona
United States Dr. Louis Saeger Minneapolis Minnesota

Sponsors (2)

Lead Sponsor Collaborator
joimax, Inc. MileStone Research Organization

Country where clinical trial is conducted

United States, 

References & Publications (7)

Choi WS, Kim JS, Ryu KS, Hur JW, Seong JH, Cho HJ. Endoscopic Radiofrequency Ablation of the Sacroiliac Joint Complex in the Treatment of Chronic Low Back Pain: A Preliminary Study of Feasibility and Efficacy of a Novel Technique. Biomed Res Int. 2016;201 — View Citation

Gibson JN, Cowie JG, Iprenburg M. Transforaminal endoscopic spinal surgery: the future 'gold standard' for discectomy? - A review. Surgeon. 2012 Oct;10(5):290-6. doi: 10.1016/j.surge.2012.05.001. Epub 2012 Jun 15. Review. — View Citation

Ibrahim R, Gohlke K, Decker O. Endoscopic Electrothermic (ESIJ) Procedure of the Sacroiliac Joint 21-Month Follow up Stud¡es.; 2016.

Jasper GP, Francisco GM, Choi DB, Doberstein CE, Telfeian AE. Clinical Benefits of Ultra- Minimally Invasive Spine Surgery in Awake Obese Patients in an Outpatient Setting : A Retrospective Evaluation of Transforaminal Endoscopic Discectomy with Foraminotomy. JSM Neurosurg Spine. 2014;2(5):1041.

Jasper GP, Francisco GM, Telfeian AE. Clinical success of transforaminal endoscopic discectomy with foraminotomy: a retrospective evaluation. Clin Neurol Neurosurg. 2013 Oct;115(10):1961-5. doi: 10.1016/j.clineuro.2013.05.033. Epub 2013 Jul 5. — View Citation

Pan Z, Ha Y, Yi S, Cao K. Efficacy of Transforaminal Endoscopic Spine System (TESSYS) Technique in Treating Lumbar Disc Herniation. Med Sci Monit. 2016 Feb 18;22:530-9. — View Citation

Smith AG, Capobianco R, Cher D, Rudolf L, Sachs D, Gundanna M, Kleiner J, Mody MG, Shamie AN. Open versus minimally invasive sacroiliac joint fusion: a multi-center comparison of perioperative measures and clinical outcomes. Ann Surg Innov Res. 2013 Oct 3 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in EQ-5D-3L 5 Question Health Questionnaire: patient's rate their mobility, self-care, usual activities, pain/discomfort and anxiety/depression developed by Euroqol Research Foundation.
Each of the 5 dimensions comprising the EQ-5D descriptive system is divided into 5 levels of perceived problems:
Dimension 1: Mobility Dimension 2: Self-Care Dimension 3: Usual Activities Dimension 4: Pain/Discomfort Dimension 5: Anxiety/Depression
Level 1: indicating no problem Level 2: indicating slight problems Level 3: indicating moderate problems Level 4: indicating severe problems Level 5: indicating extreme problems
A total of 3,125 possible health states is defined in this way. Each state is referred to in terms of a 5 digit code.
Lowest Score: 11111 (No problems on any of the 5 dimensions) Highest Score: 55555 (Extreme problems on all of the 5 dimensions)
Pre-Op, Peri-Op, 6-weeks, 3-months, 6-months, 12-months, 24-months post-op
Primary Change in Visual Analogue Scale (VAS) Health Questionnaire: patient's rate their health state on a scale from 0 to 100.
Score Range: 0-100mm
Low Score = Lower Pain Intensity High Score = Greater Pain Intensity
Pre-Op, Peri-Op, 6-weeks, 3-months, 6-months, 12-months, 24-months post-op
Primary Change in Oswestry Disability Index (ODI) 10 Question Health Questionnaire where patient's rate their level of back pain.
Score Range: 0-100%
Low Score = Minimal Disability High Score = Severe Disability
Pre-Op, Peri-Op, 6-weeks, 3-months, 6-months, 12-months, 24-months post-op